China's Food and Drug Administration announced Tuesday that clinical data from four Taiwanese hospitals can be used when applying for drug permits in China, a "breakthrough" that industry leaders said will give Taiwan a leg up in developing into an Asia-Pacific hub for pharmaceutical research and trials.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
-
Business
Taiwan's March PMI falls but stays in expansion mode
04/01/2026 10:12 PM -
Society
Driver in fatal Changhua crash receives suspended sentence after settlement
04/01/2026 09:19 PM -
Society
THSR launches onboard digital service for real-time passenger reports
04/01/2026 08:56 PM -
Society
Cross-party lawmakers question eased migrant domestic worker rules
04/01/2026 08:38 PM -
Society
Lawmaker urges probe into FPCC over plastics supply crunch
04/01/2026 07:55 PM